Viewing StudyNCT03766685



Ignite Creation Date: 2024-05-06 @ 12:26 PM
Last Modification Date: 2024-10-26 @ 12:59 PM
Study NCT ID: NCT03766685
Status: COMPLETED
Last Update Posted: 2023-08-08
First Post: 2018-12-05

Brief Title: A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis PSO
Sponsor: UCB Biopharma SRL
Organization: UCB Pharma

Conditions & Keywords Data

Conditions:
Name
Chronic Plaque Psoriasis
Moderate to Severe Chronic Plaque Psoriasis
Keywords:
Name View
Bimekizumab View
PSO View
Psoriasis View
Auto-Injector View